Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for Arthrofibrosis Prevention in TKA
NCT06333522Phase 4Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Jul 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of losartan in Arthrofibrosis, sponsored by NYU Langone Health. Planned start Jul 2024; status: withdrawn.
02
Drugs
losartan
03
Conditions
Arthrofibrosis
Beyond the preview
Go deeper on NCT06333522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06333522.